IDOGEN — Idogen AB (publ) | ScreenerHero

IDOGENIdogen AB (publ)

STO · SE · Health Care · Biotechnology

0.1205SEK0.00%Mkt Cap: 0 SEKP/E: —Last update: 2026-05-13

Industry Peers

Biotechnology

103.39BDKKP/E 20.1

45.12BEURP/E 29.5

Camurus AB (publ)

30.32BSEKP/E 44.9

BioArctic AB (publ)

28.78BSEKP/E 28.2

Zealand Pharma A/S

21.93BDKKP/E 3.5

Bavarian Nordic A/S

14.40BDKKP/E 12.5

Financière de Tubize SA

8.83BEURP/E 95.3

loading…

Indicators:|

Key Statistics

Valuation

P/E (Trailing)—

P/E (Forward)-1.10

PEG—

P/B6.34

P/S—

EV/EBITDA—

EV/Revenue—

EPS (TTM)—

EPS (Forward)—

Cash Flow & Leverage

FCF Yield—

FCF Margin—

Operating CF-50.70M SEK

CapEx (TTM)1.64M SEK

Net Debt/EBITDA—

Net Debt—

Technical

SMA 500.1205 (-0.0%)

SMA 2000.1205 (-0.0%)

Beta—

S&P 52W Chg—

Avg Vol (30d)0

Avg Vol (10d)—

Technical Indicators

RSI (14)100.0

MACD0.0000

MACD Signal0.0000

MACD Hist.+0.0000

BB Upper0.1205 SEK

BB Middle0.1205 SEK

BB Lower0.1205 SEK

BB Width0.00%

ATR (14)0.0000 SEK

Vol Ratio (20d)—

52W Range

—

52W High0.1205 SEK

52W Low0.1205 SEK

Profitability

Gross Margin—

EBITDA Margin—

Profit Margin—

Oper. Margin—

ROE-1321.98%

ROA-530.79%

Revenue Growth—

Earnings Growth—

Balance Sheet

Debt/Equity—

Current Ratio—

Quick Ratio—

Book Value/Sh0.0190 SEK

Cash/Share—

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 SEK

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Ownership

Shares Out.104.37M

Float—

Insiders—

Institutions—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Company

Market Cap0 SEK

Enterprise Value—

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-47.75M SEK

Revenue/Share—

Fiscal Year End—

MR Quarter—

Employees—

Last Price0.1205 SEK

CountrySE

SectorHealth Care

IndustryBiotechnology

ISIN—